Hospital biobank aims to Fast-Track rapid tests for future outbreaks
NCT ID NCT07411729
First seen Feb 18, 2026 · Last updated Jun 22, 2026 · Updated 21 times
Summary
This study is creating a large collection of leftover blood, urine, and other samples from 800 hospitalized patients. The samples will be stored with medical data to help researchers develop and evaluate rapid diagnostic tests for emerging infectious diseases and biological threats. No extra procedures are needed—only samples already taken during routine care are used. The goal is to be better prepared for future outbreaks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMUNICABLE DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
-
CHU Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Paul Brousse
RECRUITINGVillejuif, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this biobank could speed up the creation of rapid diagnostic tests for new infectious diseases and bioterrorism threats, improving outbreak response.
What could go wrong
This is an observational registry, not a treatment trial. It collects existing samples and data, so it does not directly test any intervention or guarantee that useful diagnostics will result.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.